CardioSource
WorldNews
Home Page
FEBRUARY 2016, VOL. 5, NO. 2
In This Issue
ACC.org
CLINICAL NEWS
The Journey to Value-Based Payment
13 JACC in a Flash
18 Journal Wrap
24 ACCEL
COLUMNS
35 Clinical Innovators
38 Health Tech
44 Business Consult
Mobile App Spotlight
Statin Intolerance App–
Named One of the Best
2015 Medical Apps
The ACC’s Statin Intolerance App, which
guides clinicians through the process
of managing and treating patients who
report muscle symptoms while on statin
therapy, was recently recognized as one
of the top medical apps released in 2015
by iMedicalApps. Clinicians can use the
app to evaluate possible intolerance
to a patient’s current statin prescription, follow steps to manage and treat a
patient who reports muscle symptoms
on a statin, and compare statin characteristics and drug interactions to inform
management of
LDL-related risk.
Learn more about
the Statin Intolerance App and
other ACC mobile
resources at
ACC.org/Apps.
In a blog post on ACC.org, Paul Casale, MD, MPH, a member
of ACC’s Board of Trustees and chair of the Partners in Quality
Subcommittee, discusses the journey to a value-based payment
system. The Medicare Access and CHIP Reauthorization Act of
2015 (MACRA) permanently repeals the Sustainable Growth Rate,
establishes a framework for rewarding clinicians for value over volume and streamlines quality reporting programs into one system.
MACRA also established two new payment pathways for clinicians
that will start in 2019: the Merit-Based Incentive Payment System
(MIPS) and Alternative Payment Models (APMs). “While the valuebased payment landscape continues to evolve rapidly, the time is
right to determine how ACC can more efficiently and effectively
contribute to meet cardiologists’ needs as new payment models
are implemented,” Casale writes. Read the full post at blog.acc.org.
Certified Patient Case:
A 65-year-old female is admitted to the hospital for a non-ST-segment elevation myocardial infarction. She receives a drug-eluting
stent to her right coronary artery and is discharged in stable
condition a day later on her home medications and dual antiplatelet therapy. Nine month